GlassScriptPhysician profile
Adil Yousuf
NPI 1326401860
$100,703.82
in general payments reported to CMS, 2019-2025
28 companies · $24K in 2025
The $24K reported for 2025 was more than what 91% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.11 · 2020: $713 · 2021: $6,485 · 2022: $16K · 2023: $32K · 2024: $22K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $43K · Travel and Lodging: $20K · Food and Beverage: $14K · Education: $1,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $43,000.00 |
| Travel and Lodging | $19,669.20 |
| Food and Beverage | $13,920.19 |
| Education | $1,279.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $53,697.03 | 2021-2025 | Ensite Precision, Assurity, Tacticath |
| Medtronic, INC. | $28,700.61 | 2022-2025 | Micra, Azure Xt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Boston Scientific Corporation | $7,577.14 | 2022-2025 | Watchman Access System, Versacross Access Solution, S-Icd System Magnet |
| Biotronik INC. | $4,445.31 | 2021-2025 | |
| Medical Device Business Services, INC. | $1,851.36 | 2024 | Carto 3 |
| Biosense Webster, INC. | $1,566.08 | 2019-2025 | Carto 3, Octaray Mapping Catheter, Soundstar |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $346.62 | 2020-2023 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $300.70 | 2020-2023 | Farxiga, Andexxa |
| Astellas Pharma US INC | $281.71 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $272.87 | 2020-2023 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $227.62 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $212.08 | 2021-2023 | |
| Pfizer INC. | $197.09 | 2020-2023 | |
| Shockwave Medical, INC | $183.27 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amgen INC. | $162.19 | 2020-2023 | Repatha |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $136.71 | 2023 | Indigo System |
| Abiomed | $93.17 | 2021-2023 | Impella |
| Actelion Pharmaceuticals US, INC. | $89.81 | 2021-2022 | |
| Esperion Therapeutics, INC. | $78.86 | 2020-2021 | |
| Medtronic Vascular, INC. | $60.19 | 2020 | |
| Livanova USA, INC. | $55.21 | 2020 | |
| Baxter Healthcare | $38.39 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Irhythm Technologies, INC. | $37.17 | 2020 | |
| Kestra Medical Technology Services, INC. | $22.93 | 2023 | Assure Wcd |
| Vital Connect, INC | $21.20 | 2025 | Vitalpatch Rtm |
| Endotronix, INC. | $19.83 | 2021 | |
| Cook Medical LLC | $14.87 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adil Yousuf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.